Vertex Pharmaceuticals (VRTX) Free Cash Flow (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 271.40% |
| Dec 31, 2025 | -69.41% |
| Sep 30, 2025 | 22.88% |
| Jun 30, 2025 | 19.17% |
| Mar 31, 2025 | 58.17% |
| Dec 31, 2024 | -62.21% |
| Sep 30, 2024 | 134.06% |
| Jun 30, 2024 | -408.72% |
| Mar 31, 2024 | 601.53% |
| Dec 31, 2023 | -85.62% |
| Sep 30, 2023 | 14.24% |
| Jun 30, 2023 | 25.30% |
| Mar 31, 2023 | -17.90% |
| Dec 31, 2022 | 15.92% |
| Sep 30, 2022 | -17.05% |
| Jun 30, 2022 | 21.72% |
| Mar 31, 2022 | -4.35% |
| Dec 31, 2021 | 6.68% |
| Sep 30, 2021 | 450.48% |
| Jun 30, 2021 | -129.36% |
| Mar 31, 2021 | 91.53% |
| Dec 31, 2020 | -39.45% |
| Sep 30, 2020 | -28.19% |
| Jun 30, 2020 | 28.18% |
| Mar 31, 2020 | 85.49% |
| Dec 31, 2019 | 38.25% |
| Sep 30, 2019 | -30.60% |
| Jun 30, 2019 | 45.85% |
| Mar 31, 2019 | 2.61% |
| Dec 31, 2018 | -17.06% |
| Sep 30, 2018 | 23.40% |
| Jun 30, 2018 | 30.76% |
| Mar 31, 2018 | 21.05% |
| Dec 31, 2017 | 29.83% |
| Sep 30, 2017 | -13.48% |
| Jun 30, 2017 | -35.48% |
| Mar 31, 2017 | 95.94% |
| Dec 31, 2016 | 150.97% |
| Sep 30, 2016 | 107.57% |
| Jun 30, 2016 | 192.00% |
| Mar 31, 2016 | -263.16% |
| Dec 31, 2015 | 123.45% |
| Sep 30, 2015 | 42.70% |
| Jun 30, 2015 | 46.87% |
| Mar 31, 2015 | -18.49% |
| Dec 31, 2014 | -102.65% |
| Sep 30, 2014 | 30.57% |
| Jun 30, 2014 | 27.01% |
| Mar 31, 2014 | -3,717.40% |
| Dec 31, 2013 | 116.41% |
| Sep 30, 2013 | -1,081.60% |
| Jun 30, 2013 | 96.69% |
| Mar 31, 2013 | -758.40% |
| Dec 31, 2012 | -85.20% |
| Sep 30, 2012 | -17.79% |
| Jun 30, 2012 | 3,275.73% |
| Mar 31, 2012 | -100.66% |
| Dec 31, 2011 | 1,402.08% |
| Mar 31, 2011 | -6.06% |
| Dec 31, 2010 | -3.27% |
| Sep 30, 2010 | -47.44% |
| Jun 30, 2010 | 40.59% |
| Mar 31, 2010 | -81.59% |
| Dec 31, 2009 | -316.50% |
| Sep 30, 2009 | 78.49% |
| Jun 30, 2009 | 36.17% |